Generic Drugs Are Attracting Federal Scrutiny And Action
Federal scrutiny and pilot programs are welcome, but more must be done to strengthen our generic drug supply. There's a clear path forward to solve this challenge.
(Forbes, 2025-10-22T12:36:16Z)